Patents by Inventor Weixing Zhang

Weixing Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240105091
    Abstract: The present disclosure provides a gate driving circuit, a method of driving a gate driving circuit, and a display panel. The gate driving circuit includes a plurality of driving units connected in cascade. Each driving unit includes: N shift register units; and a mode control circuit connected to the N shift register units, wherein the mode control circuit is configured to receive a control signal for the driving unit, and connect the N shift register units in one of a plurality of resolution modes under the control of the control signal.
    Type: Application
    Filed: October 20, 2023
    Publication date: March 28, 2024
    Applicant: BOE Technology Group Co., Ltd.
    Inventors: Weixing Liu, Wei Qin, Kuanjun Peng, Tieshi Wang, Chunfang Zhang, Hui Zhang, Changfeng Li, Shunhang Zhang, Kai Hou, Hongrun Wang, Liwei Liu, Yunsik Im, Wanpeng Teng, Xiaolong Li, Kai Guo, Zhiqiang Xu
  • Publication number: 20240102205
    Abstract: A multifunctional fiber with full-spectrum infrared radiation, flame retardant and antibacterial functions, including a composite masterbatch having a water content of 30-50 ppm and accounting for 10-12% by weight, polyethylene terephthalate having a water content of 25-30 ppm or polycaprolactam high polymer having a water content of 50-70 ppm and accounting for 88-90% by weight; the fiber and its fabric possess multiple functions such as spectral heating, flame retardancy, anti-bacteria and anti-virus; after being illuminated for 5-10 minutes, the temperature difference of the fiber fabric of the present invention is higher than 15-20° C., the far-infrared emissivity is greater than 98%, the radiation temperature rise is greater than 3.0° C., the CLO value is greater than 0.5, the heat transfer coefficient is greater than 18.0w/(m2k), and the thermal resistance is less than 0.05 (m2k)/w.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 28, 2024
    Inventors: Shengjun LI, Shouyun ZHANG, Yanlin SUN, Yanli LIU, Tingting QIAN, Mengna LOU, Weixing YANG
  • Patent number: 11933850
    Abstract: A device for detecting a slot wedge, an air gap and a broken rotor bar is provided, where a sequential circuit generates double concurrent pulses; the sequential circuit is connected to driving power modules; the driving power modules are connected to front-end interface circuits; the front-end interface circuits convert the double concurrent pulses into corresponding magnetic-field pulses; the magnetic-field pulses are transmitted to power supply terminals on adjacent phases of stator windings through impedance matching pins and coupled at a corresponding coil, air gap and squirrel cage rotor to generate single groups of cyclic rotating magnetic potentials; single rotating magnetic potentials are sequentially generated in adjacent slots on each of the phases of the stator windings; rotating electric potentials in magnetic circuits with two symmetrical phases are magnetically coupled to form distributed coupling magnetic field reflected full-cycle waves for reflecting a difference of a corresponding slot wedg
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: March 19, 2024
    Assignee: HANGZHOU HENUOVA TECHNOLOGY CO., LTD.
    Inventors: Yuewu Zhang, Weixing Yang, Boyan Zhao, Jie Luo, Gang Du, Chao Wang, Han Gao, Liwei Qiu, Ming Xu, Jiamin Li, Yanxing Bao, Qianyi Zhang, Zuting Cao, Junliang Liu
  • Publication number: 20240088328
    Abstract: A light-emitting device, a light-emitting substrate, and a method for manufacturing the light-emitting device. The light-emitting device includes at least one light-emitting structure. The light-emitting structure includes: a first semiconductor layer; a light-emitting layer; a second semiconductor layer, doping ions of the second semiconductor layer and a first semiconductor layer being oppositely charged; a barrier structure provided with an opening for exposing the second semiconductor layer, the orthographic projection of the opening on the base substrate being located in the orthographic projection of the light-emitting layer on the base substrate, and the area of the opening being smaller than that of the light-emitting layer; and a landing electrode located on the side of the barrier structure facing away from the second semiconductor layer, the landing electrode being in contact with the second semiconductor layer by means of the opening.
    Type: Application
    Filed: October 22, 2021
    Publication date: March 14, 2024
    Inventors: Bin QIN, Kuanjun PENG, Weixing LIU, Fangzhen ZHANG, Xue DONG, Jintao PENG, Wanpeng TENG, Xiaolong LI, Shuang SUN, Wanzhi CHEN, Guangcai YUAN, Qian JIA
  • Publication number: 20240012784
    Abstract: This application provides a data transmission apparatus and a data transmission method. The data transmission apparatus in this application includes: a first connection unit and a control unit, where the first connection unit is a connector plug or a connector socket; and the control unit is configured to: if determining that the first connection unit is in a forward insertion state, control a first data pin pair of the first connection unit to be in a first communication mode, and control a second data pin pair of the first connection unit to be in a second communication mode.
    Type: Application
    Filed: September 21, 2023
    Publication date: January 11, 2024
    Inventors: Deng Lu, Zhaohua Qian, Weixing Zhang, Jiandong Ke
  • Publication number: 20230376436
    Abstract: An apparatus with a forward-reverse insertion interface and a detection method are provided, and relate to the field of communication technologies, to improve transmission efficiency of an auxiliary channel. The forward-reverse insertion interface of the apparatus includes: a first auxiliary channel (CH1), including a first switch selection circuit (SW1) coupled to a first node (A); a second auxiliary channel (CH2), including a second switch selection circuit (SW2) coupled to a second node (B), where the second switch selection circuit (SW2) and the first switch selection circuit (SW1) are structurally asymmetrical; and a control circuit (CTRL), configured to control switching of the first switch selection circuit (SW1) to change an electrical parameter of the first node (A), and control switching of the second switch selection circuit (SW2) to change an electrical parameter of the second node (B).
    Type: Application
    Filed: July 28, 2023
    Publication date: November 23, 2023
    Inventors: Weixing ZHANG, Zhaohua QIAN, Jiandong KE
  • Publication number: 20230279001
    Abstract: The present invention relates to compounds of formula (I), wherein R1, R2, R3, R4, R5 and A are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 2, 2021
    Publication date: September 7, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Dongdong CHEN, Jianguo CHEN, Fabian DEY, Xin HONG, Xuefei TAN, Jiasu XU, Weixing ZHANG, Wei ZHU, Ge ZOU
  • Patent number: 11720629
    Abstract: The present invention provides a knowledge graph construction method and device. The method includes: obtaining structured data, where the structured data includes a first entity name of a first entity and attribute information corresponding to the first entity name, and the attribute information includes a first attribute and a first attribute value; performing, based on measurement of a similarity between the first entity and a second entity in a knowledge graph, entity alignment processing on the first entity, where the measurement of the similarity includes at least one of the following types: measurement of a character similarity, measurement of a structure similarity of a classification tree on which an entity is located, and measurement of an attribute similarity; and importing the structured data into the knowledge graph according to an entity alignment processing result. Embodiments may ensure correctness of data in the knowledge graph.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: August 8, 2023
    Assignee: ALIBABA GROUP HOLDING LIMITED
    Inventors: Yue Wang, Wei You, Weixing Zhang, Nengwei Hua
  • Patent number: 11713327
    Abstract: The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: August 1, 2023
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Fabian Dey, Buyu Kou, Haixia Liu, Hong Shen, Xiaoqing Wang, Weixing Zhang, Zhisen Zhang, Zhiwei Zhang, Wei Zhu
  • Publication number: 20230022297
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds act as antagonists of the toll-like receptors TLR7, TLR8 and/or TLR9 and are thus useful in the treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Application
    Filed: December 1, 2020
    Publication date: January 26, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jianguo CHEN, Fabian DEY, Hongtao XU, Weixing ZHANG, Wei ZHU
  • Publication number: 20230002415
    Abstract: The present invention relates to compounds of formula (I), wherein R1, R3, Y and A are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: November 18, 2020
    Publication date: January 5, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jianguo CHEN, Weixing ZHANG, Zhisen ZHANG, Wei ZHU
  • Publication number: 20220363665
    Abstract: The present invention relates to compounds of formula (I), (I), wherein R1, R2 and R3 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: September 9, 2020
    Publication date: November 17, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Haixia LIU, Hong SHEN, Weixing ZHANG, Zhiwei ZHANG, Wei ZHU
  • Publication number: 20220075507
    Abstract: A method and a device for controlling a remotely controlled mobile platform and a readable storage medium are provided. The method includes: displaying at least one function icon and at least one control icon, where the function icon represents a control program for implementing a preset function, and the control icon is used to control a control terminal and/or a remotely controlled mobile platform to execute the control program; generating, based on a selection operation of a user on the function icon, the control program associated with the selected function icon; and controlling, based on an operation of the user on the control icon, the control terminal and/or the remotely controlled mobile platform to execute the control program.
    Type: Application
    Filed: November 13, 2021
    Publication date: March 10, 2022
    Applicant: SZ DJI TECHNOLOGY CO., LTD.
    Inventors: Haoyu LI, Junfeng WU, Weixing ZHANG, Yana GUO, Zeyang FAN
  • Publication number: 20220064128
    Abstract: The present invention relates to compounds of formula (I), wherein R1-R5 and L are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 26, 2021
    Publication date: March 3, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Chungen Liang, Hongying Yun, Weixing Zhang, Kun Miao, Jianguo Chen, Yao Wu
  • Publication number: 20210395239
    Abstract: The present invention relates to compounds of formula (I), wherein R1 to R3, A and Q are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: September 25, 2019
    Publication date: December 23, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Jianguo CHEN, Haixia LIU, Yafei LIU, Hong SHEN, Weixing ZHANG, Zhiwei ZHANG, Wei ZHU
  • Publication number: 20210323977
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: August 28, 2018
    Publication date: October 21, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: HAIXIA LIU, GUOLONG WU, WEIXING ZHANG, WEI ZHU, HONG SHEN, FABIAN DEY
  • Publication number: 20210309657
    Abstract: The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: May 26, 2021
    Publication date: October 7, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Yimin HU, Yongqiang LIU, Hong SHEN, Houguang SHI, Xuefei TAN, Shixiang YAN, Weixing ZHANG, Zhiwei ZHANG, Chengang ZHOU, Mingwei ZHOU, Wei ZHU
  • Publication number: 20210309658
    Abstract: The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: May 26, 2021
    Publication date: October 7, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian DEY, Yimin HU, Yongqiang LIU, Hong SHEN, Houguang SHI, Xuefei TAN, Shixiang YAN, Weixing ZHANG, Zhiwei ZHANG, Chengang ZHOU, Mingwei ZHOU, Wei ZHU
  • Publication number: 20210300947
    Abstract: The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: June 11, 2019
    Publication date: September 30, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: FABIAN DEY, BUYU KOU, HAIXIA LIU, HONG SHEN, XIAOQING WANG, WEIXING ZHANG, ZHISEN ZHANG, ZHIWEI ZHANG, WEI ZHU
  • Publication number: 20210253575
    Abstract: The present invention relates to compounds of formula (I), wherein R1, R2, R3 and R4 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 19, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Fabian Dey, Haixia Liu, Hong Shen, Guolong Wu, Weixing Zhang, Wei Zhu